Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of ovarian function preservation with GnRH agonist during chemotherapy in premenopausal women with early breast cancer.
Huang, Yaping; Huang, Xiaoting; Huang, Xiaojia; Lin, Shen; Luo, Shaohong; Gu, Dian; Weng, Xiuhua; Xu, Xiongwei.
Afiliação
  • Huang Y; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Huang X; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Huang X; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Lin S; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Luo S; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Gu D; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Weng X; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Xu X; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Hum Reprod ; 38(6): 1099-1110, 2023 06 01.
Article em En | MEDLINE | ID: mdl-37075316

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preservação da Fertilidade / Neoplasias Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Hum Reprod Assunto da revista: MEDICINA REPRODUTIVA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preservação da Fertilidade / Neoplasias Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Hum Reprod Assunto da revista: MEDICINA REPRODUTIVA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China